| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 27,567 | $25.28 | $696.9K | 114,940 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 87,373 | $2.48 | $216.7K | 87,373 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 23,364 | $14.85 | $347.0K | 138,304 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | SALE | 23,364 | — | — | 0 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | SALE | 27,567 | — | — | 0 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 158,795 | $60.21 | $9.56M | 0 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASE | 20,491 | $22.47 | $460.4K | 158,795 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | SALE | 20,491 | — | — | 0 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | SALE | 87,373 | — | — | 0 | Aug 4, 2026 | Aug 6, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,126 | — | — | 17,126 | Feb 12, 2026 | Feb 17, 2026 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,491 | — | — | 20,491 | Feb 6, 2025 | Feb 10, 2025 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 16,835 | — | — | 16,835 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,364 | — | — | 23,364 | Feb 13, 2024 | Feb 20, 2024 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,567 | — | — | 27,567 | Feb 23, 2023 | Apr 6, 2023 ↗ | View → |
| ELVN ENLIVEN THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 87,373 | — | — | 87,373 | Feb 23, 2023 | Feb 27, 2023 ↗ | View → |